pentobarbital will reduce the extent or outcome of gefitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will lessen the level or effect of nelfinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will lower the extent or result of disopyramide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.
pentobarbital will reduce the level or result of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Intently. Think about an increase in cannabidiol dosage (determined by scientific response and tolerability) when coadministered with a solid CYP3A4 inducer.
Barbiturates could potentially cause fetal harm when administered to your Expecting woman; retrospective, case-controlled reports have instructed a link among maternal use of barbiturates and a higher-than-envisioned incidence of fetal abnormalities
pentobarbital will minimize the extent or influence of ripretinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital and olopatadine intranasal equally boost sedation. Prevent or Use Alternate Drug. Coadministration raises possibility of CNS melancholy, which can lead to additive impairment of psychomotor functionality and induce daytime impairment.
pentobarbital will decrease the extent or effect of lefamulin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Avoid coadministration of click here lefamulin with robust or average CYP3A inducers unless the advantage outweighs pitfalls. Observe for reduced efficacy.
pentobarbital will lower the level or influence of triamcinolone acetonide injectable suspension by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital decreases amounts of vandetanib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Avoid coadministration with powerful CYP3A4 inducers; these prescription drugs minimize exposure to vandetanib by as many as forty%.
pentobarbital will lessen the extent or influence of ibuprofen by influencing hepatic enzyme CYP2C9/ten metabolism. Insignificant/Importance Not known.
Contraindicated (1)pentobarbital will lower the extent or outcome of naloxegol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Utilization of naloxegol with solid CYP3A4 inducers is not really advised
pentobarbital will decrease the level or result of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.
Contraindicated (1)pentobarbital will reduce the level or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with powerful CYP3A4 inducers can lead to decreased serum concentrations and loss of antimalarial efficacy